- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on SARS-Cov-2 Induced Pulmonary Fibrosis
Total 1107 results
-
Parc de Salut MarUniversitat Pompeu FabraCompletedZinc Deficiency | Sars-CoV-2 InfectionSpain
-
University of BolognaUnknown
-
University of PittsburghCompleted
-
Rigshospitalet, DenmarkTestcenter Danmark, Statens Serum Institut; Copenhagen Emergency Medical ServicesCompletedCovid19 | SARS-CoV-2 | Rapid Antigen TestDenmark
-
Association Clinique Thérapeutique Infantile du...RecruitingSars-CoV-2 Infection | MIS-CFrance
-
Davita Clinical ResearchCompletedSARS-CoV-2 Infection | Anti-SARS-CoV-2 InfectionUnited States
-
Central Hospital, Nancy, FranceRecruitingSARS-CoV2 Infection | Proximal Tubule DysfunctionFrance
-
Centre Hospitalier Universitaire DijonNot yet recruitingAcute Respiratory Distress Syndrom (SARS-Cov 2)
-
Johns Hopkins UniversityEiger BioPharmaceuticalsTerminatedSars-CoV-2 InfectionUnited States
-
University Hospital, Basel, SwitzerlandsciCORE University of Basel; Leonhard Med IT ETH Zurich; Swiss Institute of BioinformaticsCompletedSARS Coronavirus (SARS-CoV-2) InfectionSwitzerland
-
Valneva Austria GmbHCompletedSARS-CoV-2 Virus InfectionUnited Kingdom
-
Chemi-Pharm ASRecruiting
-
Laboratorio Avi-Mex, S.A. de C.V.National Council of Science and Technology, Mexico; Instituto Nacional de Enfermedades...CompletedSARS CoV 2 InfectionMexico
-
Centre Hospitalier Régional Metz-ThionvilleCompleted
-
Société Française d'Anesthésie et de RéanimationCompletedSARS CoV 2 InfectionFrance
-
Complejo Hospitalario Universitario de AlbaceteRecruitingSARS-CoV 2 PneumoniaSpain
-
Ono Pharmaceutical Co. LtdCompletedSARS-CoV-2 Infection (COVID-19)Japan
-
Rohto Pharmaceutical Co., Ltd.CompletedSARS-CoV-2 Infection( COVID-19 )Japan
-
Centre Hospitalier Universitaire DijonCompleted
-
Belfast Health and Social Care TrustQueen's University, BelfastCompletedSARS CoV 2 InfectionUnited Kingdom
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Davita Clinical ResearchCompletedSARS-CoV-2 Infection (Asymptomatic) | SARS-CoV-2 Infection (Symptomatic)United States
-
Leidos Life SciencesUnited States Department of DefenseActive, not recruitingCOVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV InfectionUnited States
-
Hunt Regional Medical CenterRecruitingHypoxia | SARS-CoV-2 | ARDSUnited States
-
Valneva Austria GmbHCompleted
-
Central Hospital, Nancy, FranceCompletedSARS-CoV-2 | Immune System DisorderFrance
-
EpicentreInstitut Pasteur; Agence Regionale de Sante d'Ile de France; Medecins Sans Frontieres...Withdrawn
-
University Hospital, LilleCompleted
-
University of ZurichCompleted
-
University of Iowa3MWithdrawnSARS-CoV-2 Acute Respiratory Disease
-
Shanghai Junshi Bioscience Co., Ltd.UnknownCOVID-19; and High Infection Risk of SARS-CoV-2China
-
Hospital de MataróRecruiting
-
University of Colorado, DenverRecruitingPost-acute Sequelae of SARS-CoV-2 InfectionUnited States
-
University College, LondonCompleted
-
Federal State Budgetary Institution, V. A. Almazov...CompletedIncreased Risk of SARS-CoV-2 InfectionRussian Federation
-
Mohammed VI University HospitalCompletedSARS CoV 2 Infection | Hypoxemic Respiratory FailureMorocco
-
Tonix Pharmaceuticals, Inc.CompletedCOVID-19 | Long COVID | Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection | Long Haul COVIDUnited States
-
Institut National de la Santé Et de la Recherche...Assistance Publique - Hôpitaux de Paris; Samusocial de ParisCompletedSARS-COV2 InfectionFrance
-
Gilead SciencesApproved for marketingSARS-CoV2 InfectionUnited States, Israel, Belgium, Spain, Australia, Denmark, Italy, Germany, France, Portugal, United Kingdom, Poland, Switzerland, Canada, Austria, Cyprus, Czechia, Estonia, Greece, Hungary, Iceland, Ireland, Lithuania, Netherlands, Romania and more
-
PfizerCompletedCovid-19 | Immunocompromised | Breakthrough Infection | SARS-COV-2 Infection | SARS-COV-2 | ImmunosuppressedUnited States
-
University Magna GraeciaCompletedSARS CoV 2 Infection | Acute Respiratory Failure | AnticoagulantsItaly
-
NeuroActiva, Inc.Biomed Industries, Inc.UnknownCovid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)New Zealand, United States
-
Leidos Life SciencesUnited States Department of DefenseWithdrawnCOVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection
-
Mark LoebNot yet recruitingCoronavirus Infection | SARS-CoV2 InfectionCanada
-
Qihan LiNot yet recruitingSARS-CoV-2 Acute Respiratory Disease
-
Everly HealthCompletedSARS-CoV-2 Acute Respiratory DiseaseUnited States
-
Hospital del Río HortegaCompleted
-
Fondation Ophtalmologique Adolphe de RothschildCompletedEstimate, With the Contribution of Optimized MRI, the Prevalence of Neurological and Neurovascular Manifestations on Imaging in the Event of SARS-CoV-2France
-
Everly HealthCompletedSARS-CoV-2 Acute Respiratory DiseaseUnited States
-
Hospital de Clinicas José de San MartínClaudio Yaryour; Fermepin Marcelo; Luis Sarotto; Federico Rodriguez Cairoli; Angela... and other collaboratorsUnknownVirus Diseases | SARS-CoV 2 | COVID | Health Personnel Attitude | rt PCR | Personal Protective Equipment PPE